Document:

Exhibit 10.7

 

 

 

EYENOVIA, INC.

 

AMENDED AND RESTATED RIGHT OF FIRST REFUSAL
AND CO-SALE AGREEMENT

 

 September 27,
2017

 

 

 

    	 	 	 

     

    

 

Table of Contents

 

	SECTION 1 DEFINITIONS	1
	1.1	Certain Definitions.	1
	1.2	For purposes of this Agreement, the following terms have the
    following meanings:	1
	SECTION 2 RESTRICTIONS ON TRANSFER	3
	2.1	General.	3
	2.2	Notice of Proposed Transfer.	4
	SECTION 3 RIGHT OF FIRST REFUSAL	4
	3.1	Exercise by the Company.	4
	3.2	Initial Exercise by the Eligible Investors.	4
	3.3	Subsequent Exercise by the Eligible Investors.	5
	3.4	Purchase Price.	5
	3.5	Closing; Payment.	5
	3.6	Exclusion from Right of First Refusal.	5
	SECTION 4 RIGHT OF CO-SALE	6
	4.1	Exercise by the Eligible Investors.	6
	4.2	Subsequent Election to Sell by the Selling Investors.	6
	4.3	Closing; Consummation of the Co-Sale.	7
	4.4	Exclusion from Co-Sale Right.	7
	4.5	Multiple Series, Class or Type of Stock.	7
	4.6	Seller’s Right To Transfer.	7
	SECTION 5 CONDITIONS TO VALID TRANSFER	7
	5.1	Generally.	7
	5.2	Put Right.	7
	SECTION 6 RESTRICTIVE LEGEND AND STOP TRANSFER
    ORDERS	8
	6.1	Legend.	8
	6.2	Stop Transfer Instructions.	8
	SECTION 7 SECTION 7  TERMINATION	8
	7.1	Termination.	8
	SECTION 8 MISCELLANEOUS	9
	8.1	Notices.	9
	8.2	Successors and Assigns.	10
	8.3	Severability.	10
	8.4	Amendment.	10
	8.5	Continuity of Other Restrictions.	10
	8.6	Governing Law.	10
	8.7	Counterparts.	10
	8.8	Further Assurances.	10
	8.9	Conflict.	11
	8.10	Attorney’s Fees.	11
	8.11	Titles and Subtitles.	11
	8.12	Entire Agreement.	11
	8.13	Delays or Omissions.	11
	8.14	Electronic Execution and Delivery.	11
	8.15	Jurisdiction; Venue.	11
	8.16	Aggregation.	12

 

    i 

     

    

 

EYENOVIA, INC.

 

AMENDED AND RESTATED RIGHT OF FIRST REFUSAL
AND CO-SALE AGREEMENT

 

This Amended and Restated
Right of First Refusal and Co-Sale Agreement (this “Agreement”) is dated as of September 27, 2017,
and is between EYENOVIA, INC., a Delaware corporation (the “Company”), the holders of Series A Preferred
Stock of the Company as listed on Schedule 1 hereto (the “Series A Investors”), the holders of
Series A-2 Preferred Stock of the Company as listed on Schedule 2 hereto (the “Series A-2 Investors”),
the investors listed on Schedule 3 hereto (the “Series B Investors” and together with the Series
A Investors and the Series A-2 the “Investors” and each an “Investor”), and
the holders of the Company’s common stock listed on Schedule 4, as updated from time to time (each a “Holder”
and, collectively, the “Holders”).

 

RECITALS

 

The Series A Investors
and Series A-2 Investors collectively hold shares of the Company’s Series A Preferred Stock (as defined below), Series A-2
Preferred Stock (as defined below), and/or shares of Common Stock issued upon conversion thereof. The Holders hold shares of Common
Stock in the Company. The Holders, Series A Investors and Series A-2 Investors and are parties to that certain Right of First Refusal
and Co-Sale Agreement, dated as of March 18, 2015, between the Company, the Holders and such Investors (the “Prior
Agreement”).

 

The
Company proposes to sell shares of the Company’s Series B Preferred Stock to the Series B Investors pursuant to the
Series B Preferred Stock Purchase Agreement (the “Purchase Agreement”) of even date herewith (the
“Financing”). As a condition to the Financing, the Holders, the Series A Investors and the Series A-2
Investors desire to amend and restate the Prior Agreement in its entirety by entering into this Agreement to which the Series B
Investors hereby join.

 

The parties therefore agree
as follows:

 

SECTION 1

 

DEFINITIONS

 

1.1         Certain
Definitions.  For purposes of this Agreement, the following terms have the following meanings:

 

(a)          “Affiliate”
shall mean, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or
is under common control with such Person, including without limitation any subsidiary, parent, general partner, limited partner,
retired partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing that
is controlled by one or more general partners or managing members of, or shares the same management company with, such Person.

 

(b)          “Bad
Actor Disqualification” means any “bad actor” disqualification described in Rule 506(d)(1) through (viii)
under the Securities Act.

 

(c)          “Common
Stock” means the common stock of the Company.

 

(d)          “Change
of Control” means the acquisition of the Company by another entity by means of any transaction or series of related
transactions to which the Company is party (including, without limitation, any stock acquisition, reorganization, merger or consolidation
but excluding any sale of stock for capital raising purposes) other than a transaction or series of transactions in which the holders
of the voting securities of the Company outstanding immediately prior to such transaction continue to retain (either by such voting
securities remaining outstanding or by such voting securities being converted into voting securities of the surviving entity),
as a result of shares in the Company held by such holders prior to such transaction, at least fifty percent (50%) of the total
voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such transaction
or series of transactions.

 

     

     

    

 

(e)          “Convertible
Securities” means all then outstanding options, warrants, rights, convertible notes, preferred stock or other securities
of the Company directly or indirectly convertible into or exercisable for shares of Common Stock.

 

(f)           “Co-Sale
Eligible Investor” means each Eligible Investor who has not exercised its right in Sections 3.2 and/or 3.3,
as the case may be.

 

(g)          “Days”
means calendar days; provided that if any day on which a period specified in this Agreement would otherwise terminate falls on
a weekend or a federal holiday, the term “day” shall mean the next business day.

 

(h)          “Eligible
Investor” means (i) an Investor who or which, at the time in question, holds at least 300,000 shares of Series A
Preferred Stock and/or Series A-2 Preferred Stock (as may be adjusted from time to time for stock splits, stock dividends, combinations,
subdivisions, recapitalizations and the like) or (ii) an Investor who or which, at the time in question, holds any shares of Series
B Preferred Stock.

 

(i)           “Person”
shall mean any individual, corporation, partnership, trust, limited liability company, association or other entity.

 

(j)      
    “Preferred Stock” means, collectively, all shares of the Series A Preferred
Stock, all shares of Series A-2 Preferred Stock, all shares of Series B Preferred Stock and each other series of preferred
stock subsequently issued by the Company.

 

(k)          “Rights
of Co-Sale” means the rights of co-sale provided to the Co-Sale Eligible Investors in Section 4.

 

(l)           “Rights
of First Refusal” means the rights of first refusal provided to the Company and the Eligible Investors in Section
3.

 

(m)         “Seller”
means any holder of Common Stock or Preferred Stock proposing to Transfer Seller Shares.

 

(n)          “Seller
Shares” means all shares of Common Stock and Preferred Stock of the Company owned as of the date hereof or hereafter
acquired by any stockholder, as adjusted for any stock splits, stock dividends, combinations, subdivisions, recapitalizations and
the like.

 

(o)          “Series
A Preferred Stock” means the Series A Preferred Stock, par value $0.0001 per share.

 

(p)          “Series
A-2 Preferred Stock” means the Series A-2 Preferred Stock, par value $0.0001 per share.

 

(q)         
“Series B Preferred Stock” means the Series B Preferred Stock, par value $0.0001 per share.

 

(r)           “Transfer,” “Transferring,” “Transferred,” or words
of similar import, mean and include any sale, assignment, encumbrance, hypothecation, pledge, conveyance in trust, gift, transfer
by bequest, devise or descent, or other transfer or disposition of any kind, including but not limited to transfers to receivers,
levying creditors, trustees or receivers in bankruptcy proceedings or general assignees for the benefit of creditors, whether voluntary
or by operation of law, directly or indirectly, except:

 

    	 	2	 

     

    

 

(i)          any
bona fide pledge made pursuant to a bona fide loan transaction that creates a mere security interest, if the
pledgee executes a counterpart copy of this Agreement and becomes bound thereby as a Seller in the event that and to the extent
that such pledgee ever acquires ownership of such shares;

 

(ii)         any
transfers of Seller Shares by a Seller to Seller’s spouse, ex-spouse, domestic partner, lineal descendant or antecedent,
brother or sister, the adopted child or adopted grandchild, or the spouse or domestic partner of any child, adopted child, grandchild
or adopted grandchild of Seller, or to a trust or trusts for the exclusive benefit of Seller or those members of Seller’s
family specified in this Section 1.1(n)(ii) or transfers of Seller Shares by Seller by devise or descent; provided
that, in all cases, the transferee or other recipient executes a counterpart copy of this Agreement and becomes bound thereby as
was Seller;

 

(iii)        any
bona fide gift effected for tax planning purposes, provided that the pledgee, transferee or donee or other recipient executes a
counterpart copy of this Agreement and becomes bound thereby as was Seller;

 

(iv)         any
transfer to the Company or an Eligible Investor pursuant to the terms of this Agreement; and

 

(v)          any
repurchase of Seller Shares by the Company pursuant to agreements under which the Company has the option to repurchase such Seller
Shares upon the occurrence of certain events, such as termination of employment, or in connection with the exercise by the Company
of any rights of first refusal.

 

If a Seller plans to make
any of the above excepted transfers, then, prior to transferring its Seller Shares, the Seller shall deliver to the Company a written
notice stating: (i) Seller’s bona fide intention to make an excepted transfer of its Seller Shares; (ii) the name, address
and phone number of each proposed transferee; (iii) the aggregate number of Seller Shares to be transferred to each proposed transferee;
and (iv) the section in this agreement upon which Seller is relying in making an excepted transfer; and (v) whether any proposed
transferee or any of its directors, executive officers, other officers that may serve as a director or officer of any company in
which it invests, general partners or managing members of any person that would be deemed a beneficial owner of those securities
(in accordance with Rule 506(d) of the Securities Act) is subject to any Bad Actor Disqualification (except for Bad Actor Disqualifications
covered by Rule 506(d)(2) or (d)(3) under the Securities Act and disclosed, reasonably in advance of the transfer, in writing in
reasonable detail to the Company.

 

SECTION 2

 

RESTRICTIONS ON TRANSFER

 

2.1         General.
Before a Seller may Transfer any Seller Shares, Seller must comply with the provisions of Section 2.2, Section 3
and Section 4. Each Seller represents and warrants that it is the sole legal and beneficial owner of its Seller Shares
and, subject to any restrictions imposed under the Company’s certificate of incorporation or bylaws, as currently in effect,
or under any restricted stock purchase agreement with the Company, that no other person or entity has any interest (other than
a community property interest) in such shares.

 

    	 	3	 

     

    

 

2.2         Notice
of Proposed Transfer. Prior to Seller Transferring any of its Seller Shares, Seller shall deliver to the Company and the
Eligible Investors a written notice (the “Transfer Notice”) in substantially the form attached hereto as Exhibit
A, stating: (i) Seller’s bona fide intention to Transfer such Seller Shares; (ii) the name, address and phone
number of each proposed purchaser or other transferee (each, a “Proposed Transferee”); (iii) the
aggregate number of Seller Shares proposed to be Transferred to each Proposed Transferee (the “Offered
Shares”); (iv) the bona fide cash price or, in reasonable detail, other consideration for which Seller proposes
to Transfer the Offered Shares (the “Offered Price”); and (v) each Eligible Investor’s right
to exercise either its Right of First Refusal or its Right of Co-Sale (but not both rights) with respect to the Offered
Shares; and (vi) whether any Proposed Transferee or any of its directors, executive officers, other officers that may serve
as a director or officer of any company in which it invests, general partners or managing members or any person that would be
deemed a beneficial owner of the Offered Shares (in accordance with Rule 506(d) of the Securities Act) is subject to any Bad
Actor Disqualification (except for Bad Actor Disqualifications covered by Rule 506(d)(2) or (d)(3) under the Securities Act
and disclosed, reasonably in advance of the transfer, in writing in reasonable detail to the Company.)

 

2.3         Transfers
of Series B Preferred Stock. Notwithstanding anything herein to the contrary, the restrictions set forth in this Section
2 shall not apply to Transfers of shares of Series B Preferred Stock (or any Common Stock issuable upon conversion thereof)
by a Series B Investor (i) to any Affiliate thereof or (ii) to the Series B Investor, as trustee, or any other Person approved
by the Board, as trustee, of any trust established for the benefit of such Series B Investor or their family members (a “Series
B Permitted Transfer”). Neither the Company nor any Eligible Investor shall have a right of first refusal with respect
to any Series B Permitted Transfers pursuant to Section 3 below nor shall any Eligible Investor have any co-sale rights
with respect to any Series B Permitted Transfers pursuant to Section 4 below.

 

SECTION 3

 

RIGHT OF FIRST REFUSAL

 

3.1         Exercise
by the Company.

 

 

(a)          For
a period of twenty (20) days (the “Initial Exercise Period”) after the last date on which the Transfer
Notice is, pursuant to Section 8.1, deemed to have been delivered to the Company and all Eligible Investors, the Company
shall have the right to purchase all or any part of the Offered Shares on the terms and conditions set forth in this Section 3.
In order to exercise its right hereunder, the Company must deliver written notice to Seller within the Initial Exercise Period.

 

(b)          Upon
the earlier to occur of (i) the expiration of the Initial Exercise Period or (ii) the time when Seller has received written confirmation
from the Company regarding its exercise of its Right of First Refusal, the Company shall be deemed to have made its election with
respect to the Offered Shares, and the shares for which the Eligible Investors may exercise their Rights of First Refusal (as described
below) shall be correspondingly reduced, if appropriate.

 

3.2         Initial
Exercise by the Eligible Investors.

 

(a)          Subject
to the limitations of this Section 3.2, during the Initial Exercise Period, the Eligible Investors shall have the right
to purchase, in the aggregate, all or any part of the Offered Shares not purchased by the Company pursuant to Section 3.1
(the “Remaining Shares”) on the terms and conditions set forth in this Section 3. In order to
exercise its rights hereunder, such Eligible Investor must provide written notice delivered to Seller within the Initial Exercise
Period.

 

(b)          To
the extent the aggregate number of shares that the Eligible Investors desire to purchase (as evidenced in the written notices delivered
to Seller) exceeds the Remaining Shares, each Eligible Investor so exercising will be entitled to purchase its pro rata share of
the Remaining Shares, which shall be equal to that number of the Remaining Shares equal to the product obtained by multiplying
(x) the number of Remaining Shares by (y) a fraction, (i) the numerator of which shall be the number of shares of Common Stock
(assuming conversion of all Preferred Stock into Common Stock) held by such Eligible Investor on the date of the Transfer Notice
and (ii) the denominator of which shall be the number of shares of Common Stock (assuming conversion of all Preferred Stock into
Common Stock) held on the date of the Transfer Notice by all Eligible Investors exercising their Rights of First Refusal (“Pro
Rata ROFR Share”).

 

    	 	4	 

     

    

 

(c)          Within
five (5) days after the expiration of the Initial Exercise Period, Seller will give written notice to the Company and each Eligible
Investor specifying the number of Offered Shares to be purchased by the Company and each Eligible Investor exercising its Right
of First Refusal (the “ROFR Confirmation Notice”). The ROFR Confirmation Notice shall also specify the
number of Offered Shares not purchased by the Company or the Eligible Investors, if any, pursuant to Sections 3.1 and 3.2 (“Unsubscribed
Shares”) and shall list each Participating Investor’s (as defined in Section 3.3) Subsequent Pro Rata Share (as described
in Section 3.3) of any such Unsubscribed Shares.

 

3.3         Subsequent
Exercise by the Eligible Investors. To the extent that there remain any Unsubscribed Shares, each Eligible Investor electing
to exercise its right to purchase at least its full Pro Rata ROFR Share of the Remaining Shares under Section 3.2 (a “Participating
Investor”) shall have a right to purchase all or any part of the Unsubscribed Shares; however, to the extent the
aggregate number of shares that the Participating Investors desire to purchase (as evidenced in written notices delivered to the
Seller) exceeds the remaining Unsubscribed Shares, each Participating Investor so exercising (an “Electing Participating
Investor”) will be entitled to purchase that number of the Unsubscribed Shares equal to the product obtained by multiplying
(x) the number of Unsubscribed Shares by (y) a fraction, (i) the numerator of which shall be the number of shares of Common Stock
(assuming conversion of all Preferred Stock into Common Stock) held on the date of the Transfer Notice by such Electing Participating
Investor and (ii) the denominator of which shall be the number of shares of Common Stock (assuming conversion of all Preferred
Stock into Common Stock) held on the date of the Transfer Notice by all Electing Participating Investors (“Subsequent
Pro Rata Share”). In order to exercise its rights hereunder, such Electing Participating Investor must provide written
notice to Seller with a copy to the Company and each Eligible Investor within seven (7) days after the expiration of the Initial
Exercise Period (the “Subsequent Exercise Period”).

 

3.4         Purchase
Price. The purchase price for the Offered Shares to be purchased by the Company or by an Eligible Investor exercising its
Right of First Refusal under this Agreement will be the Offered Price, and will be payable as set forth in Section 3.5.
If the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration will be determined
by the Board of Directors of the Company in good faith, which determination will be binding upon the Company, each Eligible Investor
and Seller, absent fraud or error.

 

3.5         Closing;
Payment. Subject to compliance with applicable state and federal securities laws, the Company and the Eligible Investors exercising
their Rights of First Refusal shall effect the purchase of all or any portion of the Offered Shares, including the payment of
the purchase price, within ten (10) days after the later of (i) delivery of the ROFR Confirmation Notice and (ii) Delivery of
the Co-Sale Confirmation Notice (as defined in Section 4.1(c)), (iii) expiration of the Subsequent Exercise Period, and (iv) expiration
of the Subsequent Co-Sale Period (as defined in Section 4.2) (the “Right of First Refusal Closing”).
Payment of the purchase price will be made, at the option of the party exercising its Right of First Refusal, (i) in cash (by
check), (ii) by wire transfer or (iii) by cancellation of all or a portion of any outstanding indebtedness of Seller to the Company
or the Eligible Investor, as the case may be, or (iv) by any combination of the foregoing, in each case, net of applicable withholding
taxes. At such Right of First Refusal Closing, Seller shall deliver to each of the Company and the Eligible Investors exercising
their Rights of First Refusal, one or more certificates, properly endorsed for transfer, representing such Offered Shares so purchased.

 

3.6         Exclusion
from Right of First Refusal. This Right of First Refusal shall not apply with respect to shares sold and to be sold by Eligible
Investors pursuant to the Right of Co-Sale (set forth in Section 4) or with respect to any Series B Permitted Transfer.

 

    	 	5	 

     

    

 

SECTION 4

 

RIGHT OF CO-SALE

 

4.1         Exercise
by the Eligible Investors.

 

(a)          Subject
to the limitations of this Section 4, to the extent that the Company and the Eligible Investors do not exercise their respective
Rights of First Refusal with respect to all or any part of the Offered Shares or the Remaining Shares, as applicable, pursuant
to Section 3, then, each Eligible Investor who has not exercised its Right of First Refusal pursuant to Section 3.2 or
3.3 (a “Co-Sale Eligible Investor”) shall have the right to participate in such sale of the Offered
Shares which are not being purchased by the Company or the Eligible Investors pursuant to their respective Rights of First Refusal
(“Residual Shares”), on the same terms and conditions as specified in the Transfer Notice, to the extent
described in Section 4.1(b). To exercise its rights hereunder, each Co-Sale Eligible Investor (a “Selling Investor”)
must have provided a written notice to Seller within the Initial Exercise Period indicating the number of shares it holds that
it wishes to sell pursuant to this Section 4.1.

 

(b)          Each
Selling Investor will be entitled to sell up to its pro rata share of the Residual Shares, which shall be equal to the product
obtained by multiplying (x) the number of Residual Shares by (y) a fraction, (i) the numerator of which shall be the number of
shares of Common Stock (assuming conversion of all Preferred Stock into Common Stock) held on the date of the Transfer Notice by
such Selling Investor and (ii) the denominator of which shall be the number of shares of Common Stock (assuming conversion of all
Preferred Stock into Common Stock) held on the date of the Transfer Notice by Seller and the Selling Investors (“Pro
Rata Co-Sale Share”).

 

(c)          Within
ten (10) days after the expiration of the Initial Exercise Period, Seller will give written notice to the Company and each Selling
Investor specifying the number of Residual Shares to be sold by each Selling Investor exercising its Right of Co-Sale (the “Co-Sale
Confirmation Notice”). The Co-Sale Confirmation Notice shall also specify the number of Residual Shares not being sold by
the Selling Investors, if any, pursuant to Section 4 (the “Unsubscribed Residual Shares”) and shall list each Participating
Co-Sale Investor’s (as defined in Section 4.2) Subsequent Pro Rata Co-Sale Share (as described in Section 4.2) of
any such Unsubscribed Residual Shares.

 

4.2         Subsequent
Election to Sell by the Selling Investors. To the extent that there remain any Unsubscribed Residual Shares, each Selling
Investor electing to exercise its right to sell at least its full Pro Rata Co-Sale Share of the Residual Shares under Section
4.1 (a “Participating Co-Sale Investor”) shall have a right to sell all or any part of the Unsubscribed
Residual Shares; however, to the extent the aggregate number of additional shares that the Participating Co-Sale Investors desire
to sell (as evidenced in written notices delivered to the Seller) exceeds the Unsubscribed Residual Shares, each Participating
Co-Sale Investor so exercising (an “Electing Participating Co-Sale Investor”) will be entitled to sell
that number of the Unsubscribed Residual Shares equal to the product obtained by multiplying (x) the number of Unsubscribed Residual
Shares by (y) a fraction, (i) the numerator of which shall be the number of shares of Common Stock (assuming conversion of all
Preferred Stock into Common Stock) held by such Electing Participating Co-Sale Investor on the date of the Transfer Notice and
(ii) the denominator of which shall be the number of shares of Common Stock (assuming conversion of all Preferred Stock into Common
Stock) held on the date of the Transfer Notice by all Electing Participating Co-Sale Investors (“Subsequent Pro Rata
Co-Sale Share”). In order to exercise its rights hereunder, such Electing Participating Co-Sale Investor must provide
written notice to Seller with a copy to the Company and each Eligible Investor within twelve (12) days after expiration of the
Initial Exercise Period (the “Subsequent Co-Sale Period”).

 

    	 	6	 

     

    

 

4.3         Closing;
Consummation of the Co-Sale. Subject to compliance with applicable state and federal securities laws, the sale of the Residual
Shares by the Selling Investors shall occur within ten (10) days after the later of (i) delivery of the Co-Sale Confirmation Notice
and (ii) expiration of the Subsequent Co-Sale Period (the “Co-Sale Closing”). If a Selling Investor exercised the
Right of Co-Sale in accordance with this Section 4, then such Selling Investor shall deliver to Seller at or before the
Co-Sale Closing, one or more certificates, properly endorsed for Transfer, representing the number of Residual Shares to which
the Selling Investor is entitled to sell pursuant to this Section 4. At the Co-Sale Closing, Seller shall cause such certificates
or other instruments to be Transferred and delivered to the Transferee pursuant to the terms and conditions specified in the Transfer
Notice, and Seller will remit, or will cause to be remitted, to each Selling Investor, at the Co-Sale Closing, that portion of
the proceeds of the Transfer to which each Selling Investor is entitled by reason of each Selling Investor’s participation
in such Transfer pursuant to the Right of Co-Sale, net of applicable withholding taxes.

 

4.4         Exclusion
from Co-Sale Right. This Right of Co-Sale shall not apply with respect to Common Stock (including shares issued or issuable
upon conversion of Preferred Stock) sold or to be sold to Eligible Investors or the Company pursuant to the Right of First Refusal
or with respect to any Series B Permitted Transfer.

 

4.5         Multiple
Series, Class or Type of Stock. If the Offered Shares consist of more than one series, class or type of security, Seller has
the right to Transfer hereunder each such series, class or type; provided that if, as to the Right of Co-Sale, a Selling Investor
does not hold any of such series, class or type and the Proposed Transferee is not willing, at the Co-Sale Closing, to purchase
some other series, class or type of security from such Selling Investor, or is unwilling to purchase any security from such Selling
Investor at the Co-Sale Closing, then such Selling Investor will have the put right (the “Put Right”)
set forth in Section 5.2.

 

4.6         Seller’s
Right To Transfer. If any of the Offered Shares remain available after the exercise of all Rights of First Refusal and all
Rights of Co-Sale, then the Seller shall be free to Transfer, subject to Section 5, any such remaining shares to the Proposed
Transferee at the Offered Price or a higher price in accordance with the terms set forth in the Transfer Notice; provided, however,
that if the Offered Shares are not so Transferred during the seventy-two (72) day period following the deemed delivery of the
Transfer Notice, then Seller may not Transfer any of such remaining Offered Shares without complying again in full with the provisions
of this Agreement.

 

SECTION 5

 

CONDITIONS TO VALID TRANSFER

 

5.1         Generally.
Any attempt by any Seller to Transfer any Seller Shares in violation of any provision of this Agreement will be void. No securities
shall be transferred by Seller unless (i) such Transfer is made in compliance with all of the terms of this Agreement and all
applicable federal and state securities laws and (ii) prior to such Transfer, the transferee or transferees sign a counterpart
to this Agreement pursuant to which it or they agree to be bound by the terms of this Agreement. The Company will not be required
to (A) transfer on its books any shares that have been Transferred in violation of any provisions of this Agreement or (B) to
treat as owner of such shares, or accord the right to vote or pay dividends to any purchaser, donee or other transferee to whom
such shares may have been so Transferred.

 

5.2         Put
Right. If a Seller Transfers any Seller Shares in contravention of the Right of Co-Sale under this Agreement (a “Prohibited
Transfer”), or if the Proposed Transferee of Offered Shares desires to purchase a class, series or type of stock
offered by Seller but not held by a Selling Investor, or the Proposed Transferee is unwilling to purchase any securities from
a Selling Investor, such Selling Investor may, by delivery of written notice to such Seller (a “Put Notice”)
within ten (10) days after the later of (i) the Co-Sale Closing and (ii) the date on which such Selling Investor becomes aware
of the Prohibited Transfer or the terms thereof, require such Seller to purchase from such Selling Investor that number of shares
of Preferred Stock (on an as-converted basis) or Common Stock (subject to Section 5.2(b)) that is equal to the number of
Residual Shares such Selling Investor would have been entitled to Transfer to the purchaser (the “Put Shares”).
Such sale shall be made on the following terms and conditions:

 

    	 	7	 

     

    

 

(a)          The
price per share at which the Put Shares are to be sold to Seller shall be equal to the price per share that the Selling Investor
would have received at the Co-Sale Closing of such Prohibited Transfer if such Selling Investor had sold such Put Shares at the
Co-Sale Closing. Such purchase price of the Put Shares shall be paid in cash or such other consideration as Seller received in
the Prohibited Transfer or at the Co-Sale Closing. Seller shall also reimburse the Selling Investor for any and all fees and expenses,
including, but not limited to, legal fees and expenses, incurred pursuant to the exercise or attempted exercise of such Selling
Investor’s Rights of Co-Sale pursuant to Section 4 or in the exercise of its rights under this Section 5 with
respect to the Put Shares.

 

(b)          The
Put Shares of Stock to be sold to Seller shall be of the same class or type as Transferred in the Prohibited Transfer or at the
Co-Sale Closing if such Selling Investor then owns securities of such class or type. If such Selling Investor does not own any
of such class or type, the Put Shares shall be shares of Common Stock (or Preferred Stock convertible into Common Stock at the
option of the holder thereof).

 

(c)          The
closing of such sale to Seller will occur within ten (10) days after the date of such Selling Investor’s Put Notice to such
Seller. At such closing, the Selling Investor shall deliver to Seller the certificate or certificates representing the Put Shares
to be sold, each certificate to be properly endorsed for transfer, and immediately upon receipt thereof, such Seller shall pay
the aggregate purchase price therefor, and the amount of reimbursable fees and expenses, as specified in Section 5.2(a).

 

SECTION 6

 

RESTRICTIVE LEGEND AND
STOP TRANSFER ORDERS

 

6.1         Legend.
Each holder of Common Stock or Preferred Stock understands and agrees that the Company will cause the legend set forth below,
or a legend substantially equivalent thereto, to be placed upon any certificate(s) or other documents or instruments evidencing
ownership of Seller Shares by each holder of Common Stock or Preferred Stock:

 

THE SHARES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO AND MAY ONLY BE SOLD, DISPOSED OF OR OTHERWISE TRANSFERRED IN COMPLIANCE WITH CERTAIN RIGHTS OF FIRST REFUSAL AND
RIGHTS OF CO-SALE AS SET FORTH IN A RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT ENTERED INTO BY THE HOLDER OF THESE SHARES, THE
COMPANY AND STOCKHOLDERS OF THE COMPANY. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY. SUCH RIGHTS
OF FIRST REFUSAL AND RIGHTS OF CO-SALE ARE BINDING ON TRANSFEREES OF THESE SHARES.

 

6.2         Stop
Transfer Instructions. In order to ensure compliance with the restrictions referred to herein, each Seller agrees that the
Company may issue appropriate “stop transfer” certificates or instructions in the event of a Transfer in violation
of any provision of this Agreement and that it may make appropriate notations to the same effect in its records.

 

SECTION 7

 

TERMINATION

 

7.1         Termination.
The Eligible Investors’ Rights of First Refusal and Rights of Co-Sale shall terminate upon the earliest to occur of (i)
the closing of a Qualified Public Offering (as defined below), (ii) the date on which this Agreement is terminated by a writing
executed by holders of at least a majority of the shares of Preferred Stock then held by the Investors (on an as converted to
common basis), (iii) the dissolution or winding-up of the Company, or (iv) immediately prior to the effective date of a Change
of Control. The Company’s Right of First Refusal will terminate upon the earliest to occur of (i) a written election of
the Company pursuant to an action by the Board of Directors, or (ii) the occurrence of any of (i), or (iv) in the preceding sentence.
A “Qualified Public Offering” means a bona fide, firm commitment underwritten public offering by the
Company pursuant to an effective registration statement filed under the Securities Act of 1933, as amended, covering the offer
and sale of the Company’s Common Stock, provided that the offering price per share is not less than $2.00 (as adjusted for
stock splits, stock dividends, combinations, subdivisions, recapitalizations and the like), and the aggregate gross proceeds to
the Company are not less than $20,000,000.

 

    	 	8	 

     

    

 

SECTION 8

 

MISCELLANEOUS

 

8.1         Notices.
All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or
certified mail, postage prepaid, sent by facsimile or electronic mail (if to an Investor, a Seller or any other holder of Company
securities subject to this Agreement) or otherwise delivered by hand, messenger or courier service addressed:

 

(a)          if
to an Investor, to the Investor’s address, facsimile number or electronic mail address as shown in the exhibits to this Agreement
or in the Company’s records, as may be updated in accordance with the provisions hereof;

 

(b)          if
to a Seller, to the Seller’s address, facsimile number or electronic mail address as shown in the exhibits to this Agreement
or in the Company’s records, as may be updated in accordance with the provisions hereof;

 

(c)          if
to any other holder of Company securities subject to this Agreement, to such address, facsimile number or electronic mail address
as shown in the exhibits to this Agreement or in the Company’s records, or, until any such holder so furnishes an address,
facsimile number or electronic mail address to the Company, then to the address, facsimile number or electronic mail address of
the last holder of such securities for which the Company has contact information in its records; or

 

(d)          if
to the Company, to the attention of the Chief Executive Officer or Chief Financial Officer of the Company at 315 Montgomery Street,
Suite 100, San Francisco, CA 94104, or at such other address as the Company shall have furnished to the Investors, Sellers or other
such holders, with a copy (which shall not constitute notice) to Hill Ward Henderson, 101 East Kennedy Boulevard, Suite 3700, Tampa,
Florida 33602, Attention: R. Reid Haney.

 

Each such notice or other
communication shall for all purposes of this Agreement be treated as effective or having been given (i) if delivered by hand, messenger
or courier service, when delivered (or, if sent via a nationally-recognized overnight courier service, freight prepaid, specifying
next-business-day delivery, one business day after deposit with the courier), or (ii) if sent via mail, at the earlier of its receipt
or five days after the same has been deposited in a regularly-maintained receptacle for the deposit of the United States mail,
addressed and mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation of facsimile transfer or, (iv) if sent via
electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent during normal business
hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s next business
day.

 

Subject to the limitations
set forth in Delaware General Corporation Law §232(e), each Investor, Seller or other security holder consents to the delivery
of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s certificate
of incorporation or bylaws by facsimile telecommunication to the facsimile number set forth in the exhibits to this Agreement (or
to any other facsimile number for the Investor, Seller or other security holder in the Company’s records), electronic mail
to the electronic mail address set forth in the exhibits to this Agreement (or to any other electronic mail address for the Investor,
Seller or other security holder in the Company’s records), (Hi) posting on an electronic network together with separate notice
to the Investor, Seller or other security holder of such specific posting or (iv) any other form of electronic transmission (as
defined in the Delaware General Corporation Law) directed to the Investor, Seller or other security holder. This consent may be
revoked by an Investor, Seller or other security holder by written notice to the Company and may be deemed revoked in the circumstances
specified in Delaware General Corporation Law §232.

 

    	 	9	 

     

    

 

8.2         Successors
and Assigns. This Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned, transferred,
delegated or sublicensed by any Investor without the prior written consent of the Company. Any attempt by an Investor without
such permission to assign, transfer, delegate or sublicense any rights, duties or obligations that arise under this Agreement
shall be void. Subject to the foregoing and except as otherwise provided herein, the provisions of this Agreement shall inure
to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 

8.3         Severability.
If any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or
void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement,
and such court will replace such illegal, void or unenforceable provision of this Agreement with a valid and enforceable provision
that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable
provision. The balance of this Agreement shall be enforceable in accordance with its terms.

 

8.4         Amendment.
Except as expressly provided herein, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated
other than by a written instrument referencing this Agreement and signed by the Company and the Investors holding a majority of
the Common Stock issued or issuable upon conversion of the Preferred Stock (excluding any of such shares that have been sold to
the public or pursuant to Rule 144); provided, however, that if any amendment, waiver, discharge or termination operates in a
manner that treats any Investor different from other Investors, the consent of such Investor shall also be required for such amendment,
waiver, discharge or termination. Any such amendment, waiver, discharge or termination effected in accordance with this paragraph
shall be binding upon each Seller, each Investor and each future holder of shares of Preferred Stock with rights under this Agreement.
Each Investor acknowledges that by the operation of this paragraph, the holders of a majority of the Common Stock issued or issuable
upon conversion of the Preferred Stock (excluding any of such shares that have been sold to the public or pursuant to Rule 144)
will have the right and power to diminish or eliminate all rights of such Investor under this Agreement.

 

8.5         Continuity
of Other Restrictions. Any Seller Shares not purchased by the Company or any Eligible Investor pursuant to their Right of
First Refusal hereunder will continue to be subject to all other restrictions imposed upon such Seller Shares hereunder and by
law, including any restrictions imposed under the Company’s certificate of incorporation or bylaws, or by agreement.

 

8.6         Governing
Law. This Agreement shall be governed in all respects by the internal laws of the State of Delaware, without regard to principles
of conflicts of law.

 

8.7         Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties that execute
such counterparts, and all of which together shall constitute one instrument.

 

8.8         Further
Assurances. Each party hereto agrees to execute and deliver, by the proper exercise of its corporate, limited liability company,
partnership or other powers, all such other and additional instruments and documents and do all such other acts and things as
may be necessary to more fully effectuate this Agreement.

 

    	 	10	 

     

    

 

8.9         Conflict.
In the event of any conflict between the terms of this Agreement and the Company’s certificate of incorporation or its bylaws,
the terms of the Company’s certificate of incorporation or its bylaws, as the case may be, will control. In the event of
any conflict between the terms of this Agreement and any other agreement to which a Holder is a party or by which such Holder
is bound, the terms of this Agreement will control. In the event of any conflict between the Company’s books and records
and this Agreement or any notice delivered hereunder, the Company’s books and records will control absent fraud or error.

 

8.10       Attorney’s
Fees. In the event that any suit or action is instituted to enforce any provision in this Agreement, the prevailing party
in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such
prevailing party under or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys
and accountants, which shall include, without limitation, all fees, costs and expenses of appeals.

 

8.11       Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs, exhibits and schedules
shall, unless otherwise provided, refer to sections and paragraphs hereof and exhibits and schedules attached hereto.

 

8.12       Entire
Agreement. This Agreement and the exhibits hereto constitute the full and entire understanding and agreement between the parties
with regard to the subjects hereof. No party hereto shall be liable or bound to any other party in any manner with regard to the
subjects hereof or thereof by any warranties, representations or covenants except as specifically set forth herein.

 

8.13       Delays
or Omissions. Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing to
any party to this Agreement upon any breach or default of any other party under this Agreement shall impair any such right, power
or remedy of such non-defaulting party, nor shall it be construed to be a waiver of any such breach or default, or an acquiescence
therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default
be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval
of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of
any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically
set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement,
shall be cumulative and not alternative.

 

8.14       Electronic
Execution and Delivery. A facsimile, telecopy, pdf., email or other reproduction of this Agreement may be executed by one
or more parties and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the signature
of or on behalf of such party can be seen. Such execution and delivery shall be considered valid, binding and effective for all
purposes. At the request of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement as
well as any facsimile, telecopy, pdf. or other reproduction hereof.

 

8.15       Jurisdiction;
Venue. Each of the parties hereto hereby submits and consents irrevocably to the exclusive jurisdiction of the courts of the
State of Delaware and the United States District Court for the District of Delaware for the interpretation and enforcement of
the provisions of this Agreement. Each of the parties hereto also agrees that the jurisdiction over the person of such parties
and the subject matter of such dispute shall be effected by the mailing of process or other papers in connection with any such
action such manner as may be lawful, and that service in such manner shall constitute valid and sufficient service of process.

 

    	 	11	 

     

    

 

8.16       Aggregation.
All shares of Preferred Stock of the Company held or acquired by affiliated entities or persons of an Investor (including but
not limited to: (i) a constituent partner or a retired partner of an Investor that is a partnership; (ii) a parent, subsidiary
or other affiliate of an Investor that is a corporation; (iii) an immediate family member living in the same household, a descendant,
or a trust, in the case of an Investor who is an individual; or (iv) a member of an Investor that is a limited liability company)
shall be aggregated together for the purpose of determining the availability of any rights under this Agreement which are triggered
by the beneficial ownership of a threshold number of shares of the Company’s capital stock.

 

(signature pages follow)

 

    	 	12	 

     

    

 

The parties are signing
this Amended and Restated Right of First Refusal and Co-Sale Agreement as of the date stated in the introductory clause.

 

	 	
        EYENOVIA, INC.

        a Delaware corporation

	 	 
	 	By: 	/s/ Tsontcho Ianchulev
	 	 	Name: Tsontcho Ianchulev
	 	 	Title: Chief Executive Officer

 

[Signature Page to Amended and Restated
Right of First Refusal and Co-Sale Agreement]

 

     

     

    

 

The party below herby agrees,
effective _______________, 2017, to become a party to this Amended and Restated Right of First Refusal and Co-Sale Agreement and
for all purposes of this Amended and Restated Right of First Refusal and Co-Sale Agreement the party below shall be included within
the term Investor.

 

	 	INVESTOR:
	 	 
	 	 
	 	(Print investor name)
	 	 
	 	 
	 	(Signature)
	 	 
	 	 
	 	(Print name of signatory, if signing for an entity)
	 	 
	 	 
	 	(Print title of signatory, if signing for an entity)

 

[Signature Page to Amended and Restated
Right of First Refusal and Co-Sale Agreement]

 

     

     

    

 

Schedule 1

Series A Investors

	Name, Address and E-Mail
	 
	 

 

     

     

    

 

Schedule 2

Series A-2 Investors

	Name, Address and E-Mail
	 
	 

 

     

     

    

 

Schedule 3

Series B Investors

	Name, Address and E-Mail
	 
	 

 

     

     

    

 

	
        Schedule 4

        Holders

	 
	Name, Address and E-Mail
	 
	 

 

     

     

    

 

EXHIBIT A

 

FORM OF

NOTICE OF SHARE TRANSFER

 

Notice of Transfer

 

I intend to transfer shares
of the Company’s stock as indicated below (the “Offered Shares”).

 

Notice of Rights

 

Pursuant to the Amended
and Restated Right of First Refusal and Co-Sale Agreement, dated as of _________________ (the “Agreement”),
I write to inform you of your Right of First Refusal and your Right of Co-Sale (each as defined in the Agreement) with respect
to the Offered Shares. If you choose to do so, you may exercise one (but not both) of these rights with respect to the Offered
Shares by returning this notice to me, at the address below, with a copy to Eyenovia, Inc. If you decline your right to do so,
you do not need to return anything. Your failure to return this notice on a timely basis will indicate that you have declined to
exercise your Right of First Refusal and Right of Co-Sale with respect to the Offered Shares.

 

Election

 

	I exercise my Right of First Refusal	 ̈
	 	 
	I exercise my Right of Co-Sale	 ̈

 

I wish to (circle one, not both) buy / sell
______shares of ________stock.

 

Description of Transfer

 

		1.	Type and aggregate number of shares to be transferred:

 

		2.	Type of transfer (please check one):

 

		 ̈	Sale

 

		 ̈	Other. Describe:

 

     

     

    

 

		3.	Proposed transferees:

 

	 	Name and address	 	Type, amount and price of shares
	 	
         

        1.    [insert
        name of proposed transferee]

        [insert address
        of proposed transferee]

        [insert phone
        number of proposed transferee]
	 	
         

        [enter amount, type and price of shares]

	 	
         

        2.    [insert
        name of proposed transferee]

        [insert address
        of proposed transferee]

        [insert
phone number of proposed transferee]
	 	
         

        [enter amount, type and price of shares]

 

		4.	Consideration:

 

		·	Total cash consideration:

 

		·	Total fair market value of non-cash consideration (if any) as of the date of the notice:

 

		·	Describe any non-cash consideration in reasonable detail:

 

[Specify applicable return dates for the
notice]. There will be no extension of this deadline.

 

[Enter seller’s name and address]

 

[Enter the company’s address and contact
person]Exhibit 10.8

 

EYENOVIA, INC.

 

AMENDED AND RESTATED VOTING AGREEMENT

 

September 27, 2017

 

     

     

    

 

TABLE OF CONTENTS

 

	 	 	Page
	 	 	 
	Section 1 VOTING	2
	 	 	 
	1.1	General	2
	 	 	 
	Section 2 Election of Directors	3
	 	 	 
	2.1	Voting	3
	2.2	Designation of Directors	3
	2.3	Current Designees	3
	2.4	Changes in Designees	3
	2.5	Size of Board	4
	2.6	No Liability for Election of Recommended Director.	4
	2.7	No “Bad Actor” Designees	4
	 	 	 
	Section 3 Drag-along right	4
	 	 	 
	3.1	Drag-Along Rights	4
	3.2	Conditions to Drag-Along Right	5
	 	 	 
	Section 4 TERMINATION	7
	 	 	 
	4.1	Termination	7
	 	 	 
	Section 5 Additional Shares	7
	 	 	 
	5.1	Additional Shares	7
	 	 	 
	Section 6 Restrictive Legend	7
	 	 	 
	6.1	Restrictive Legend	7
	 	 	 
	Section 7 miscellaneous	7
	 	 	 
	7.1	Certain Definitions	7
	7.2	Notices	8
	7.3	Successors and Assigns	8
	7.4	Governing Law	8
	7.5	Titles and Subtitles	8
	7.6	Further Assurances	9
	7.7	Entire Agreement	9
	7.8	No Grant of Proxy	9
	7.9	Not a Voting Trust	9
	7.10	Specific Performance	9
	7.11	Amendment	9
	7.12	No Waiver	9
	7.13	Attorney’s Fees	10
	7.14	Severability	10
	7.15	Counterparts	10
	7.16	Dispute Resolution.	10

 

     

     

    

 

EYENOVIA, INC.

 

AMENDED AND RESTATED VOTING AGREEMENT

 

This AMENDED AND RESTATED
VOTING AGREEMENT (this “Agreement”) is made as of September 27, 2017, by and among EYENOVIA, INC.,
a Delaware corporation (the “Company”), the holders of Series A Preferred Stock of the Company as listed
on Schedule 1 hereto (the “Series A Investors”), the holders of Series A-2 Preferred Stock of
the Company as listed on Schedule 2 hereto (the “Series A-2 Investors”), the investors listed
on Schedule 3 hereto (the “Series B Investors” and together with the Series A Investors and the
Series A-2 the “Investors” and each an “Investor”), and the holders of the
Company’s common stock listed on Schedule 4, as updated from time to time (each a “Holder”
and, collectively, the “Holders”). The Holders and the Investors are referred to herein collectively
as the “Voting Parties.” Capitalized terms used and not otherwise defined herein shall have the meanings
given to such terms in the Company’s Second Amended and Restated Certificate of Incorporation, dated as of the date hereof
(the “Charter”).

 

RECITALS

 

The Series A Investors
and Series A-2 Investors collectively hold shares of the Company’s Series A Preferred Stock (as defined below), Series A-2
Preferred Stock (as defined below), and/or shares of Common Stock issued upon conversion thereof. The Holders hold shares of Common
Stock in the Company. The Holders, Series A Investors and Series A-2 Investors and are parties to that certain Voting Agreement,
dated as of March 18, 2015, between the Company, the Holders and such Investors (the “Prior Agreement”).

 

The Charter provides that
(i) the holders of shares of the Company’s Preferred Stock, voting as a separate class, shall be entitled to elect three
directors (the “Preferred Directors”), (ii) the holders of the Company’s common stock shall be
entitled to elect one director (the “Common Director”) and (iii) the holders of the Company’s common
stock and preferred stock, voting together shall be entitled to elect any additional directors (the “Additional Directors”).

 

The
Company proposes to sell shares of the Company’s Series B Preferred Stock to the Series B Investors pursuant to the
Series B Preferred Stock Purchase Agreement (the “Purchase Agreement”) of even date herewith (the
“Financing”). As a condition to the Financing, the Holders, the Series A Investors and the Series A-2
Investors desire to amend and restate the Prior Agreement in its entirety by entering into this Agreement to which the Series B
Investors hereby join.

 

The parties therefore agree
as follows:

 

Section 1

 

VOTING

 

1.1         General. 
During the term of this Agreement, the Voting Parties each agree to vote all shares of the Company’s voting securities now
or hereafter owned by them, whether beneficially or otherwise, or as to which they have voting power (the “Shares”)
in accordance with the provisions of this Agreement.

 

    	 	- 2 -	 

     

    

 

Section 2

 

Election of Directors

 

2.1         Voting. 
During the term of this Agreement, each Voting Party agrees to vote all Shares in such manner as may be necessary to elect (and
maintain in office) as members of the Company’s board of directors (the “Board”) the following
individuals:

 

(a)          The
three Preferred Designees (as defined below) as the Preferred Directors; and

 

(b)          The
Common Designee (as defined below) as the Common Director.

 

2.2         Designation
of Directors.  The designees to the Board described above (each a “Designee”) shall be selected
as follows:

 

(a)          The
“Preferred Designees” shall be chosen, one each, by Private Medical Equity, LLC Holdings, Senju Pharmaceutical
Co. Ltd. and Fred Eshelman, for so long as each holds at least fifteen percent (15%) of the Shares initially purchased by such
investor (as adjusted for stock splits, dividends, combination, reorganizations and the like).

 

(b)          The
“Common Designee” shall be chosen by Point Guard Partners for so long as it holds at least fifteen percent
(15%) of the Shares initially purchased by it (as adjusted for stock splits, dividends, combination, reorganizations and the like).

 

2.3         Current
Designees.  For the purpose of this Agreement, the directors of the Company shall be deemed to include the following Designees:

 

(a)          The
Preferred Designees: Curt LaBelle, Shuhei Yoshida and Fred Eshelman;

 

(b)          The
Common Designee: Ernest Mario;

 

(c)          The
Chief Executive Officer: Tsontcho Ianchulev.

 

2.4         Changes
in Designees.  From time to time during the term of this Agreement, Voting Parties who hold sufficient Shares to select
a Designee pursuant to this Agreement may, in their sole discretion:

 

(a)          notify
the Company in writing of an intention to remove from the Board any incumbent Designee who occupies a board seat for which such
Voting Parties are entitled to designate the Designee; or

 

(b)          notify
the Company in writing of an intention to select a new Designee for election to a board seat for which such Voting Parties are
entitled to designate the Designee (whether to replace a prior Designee or to fill a vacancy in such board seat).

 

In the event of such an
initiation of a removal or selection of a Designee under this section, the Company shall take such reasonable actions as are necessary
to facilitate such removals or elections, including, without limitation, soliciting the votes of the appropriate stockholders,
and the Voting Parties shall vote their Shares to cause: (a) the removal from the Board of the Designee or Designees so designated
for removal; and (b) the election to the Board of any new Designee or Designees so designated.

 

    	 	- 3 -	 

     

    

 

2.5         Size
of Board. 

 

During the term of this
Agreement, each Voting Party agrees to vote all Shares to maintain the authorized number of members of the Board at five (5) directors
and no Additional Directors will be designated by the Voting Parties.

 

2.6         No
Liability for Election of Recommended Director.

 

None of the parties and
no officer, director, stockholder, partner, employee or agent of any party makes any representation or warranty as to the fitness
or competence of the nominee of any party hereunder to serve on the Board by virtue of such party’s execution of this Agreement
or by the act of such party in voting for such nominee pursuant to this Agreement.

 

2.7         No
“Bad Actor” Designees.

 

Each Voting Party with
the right to designate or participate in the designation of a director as specified above hereby represents and warrants to the
Company that, to such Voting Party’s knowledge, none of the “bad actor” disqualifying events described in Rule
506(d)(1)(i)-(viii) promulgated under the Securities Act of 1933, as amended (the “Securities Act”) (each,
a “Disqualification Event”), is applicable to such Voting Party’s initial designee named above
except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. Any director
designee to whom any Disqualification Event is applicable, except for a Disqualification Event as to which Rule 506(d)(2)(ii) or
(iii) or (d)(3) is applicable, is hereinafter referred to as a “Disqualified Designee”. Each Voting Party
with the right to designate or participate in the designation of a director as specified above hereby covenants and agrees (A)
not to designate or participate in the designation of any director designee who, to such Voting Party’s knowledge, is a Disqualified
Designee and (B) that in the event such Voting Party becomes aware that any individual previously designated by any such Voting
Party is or has become a Disqualified Designee, such Voting Party shall as promptly as practicable take such actions as are necessary
to remove such Disqualified Designee from the Board and designate a replacement designee who is not a Disqualified Designee.

 

Section 3

 

Drag-along
right

 

3.1         Drag-Along
Rights.  If (i) 80% of the members of the Board then in office, including the Preferred Directors (ii) a majority-in-interest
of the common stock and (iii) a majority-in-interest of the Investors approve a Change of Control Transaction (as defined below)
(the “Selling Investors”), then each Voting Party agrees as follows:

 

(a)          if
such transaction requires stockholder approval, with respect to all Shares that such Voting Party owns or over which such Voting
Party otherwise exercises voting power, to vote (in person, by proxy or by action by written consent, as applicable) all Shares
in favor of, and adopt, such Change of Control Transaction (together with any related amendment to the Company’s certificate
of incorporation required in order to implement such Change of Control Transaction) and to vote in opposition to any and all other
proposals that could reasonably be expected to delay or impair the ability of the Company to consummate such Change of Control
Transaction;

 

(b)          if
such transaction is a Stock Sale, to sell the same proportion of shares of capital stock of the Company beneficially held by such
Voting Party as is being sold by the Selling Investors to the party to whom the Selling Investors propose to sell their Shares,
and, except as permitted in Section 3.2 below, on the same terms and conditions as the Selling Investors;

 

    	 	- 4 -	 

     

    

 

(c)          to
execute and deliver all related documentation and take such other action in support of the Change of Control Transaction as shall
reasonably be requested by the Company or the Selling Investors in order to carry out the terms and provision of this Section 3,
including, without limitation, executing and delivering instruments of conveyance and transfer, and any purchase agreement, merger
agreement, indemnity agreement, escrow agreement, consent, waiver, governmental filing, share certificates duly endorsed for transfer
(free and clear of impermissible liens, claims and encumbrances), and any similar or related documents;

 

(d)          not
to deposit, and to cause their affiliates not to deposit, except as provided in this Agreement, any Shares of the Company owned
by such party or affiliate in a voting trust or subject any Shares to any arrangement or agreement with respect to the voting of
such Shares, unless specifically requested to do so by the acquiror in connection with the Change of Control Transaction;

 

(e)          to
refrain from exercising any dissenters’ rights or rights of appraisal under applicable law at any time with respect to such
Change of Control Transaction;

 

(f)           if
the consideration to be paid in exchange for the Shares pursuant to this Subsection 3.1 includes any securities and due receipt
thereof by any Voting Party would require under applicable law (x) the registration or qualification of such securities or of any
person as a broker or dealer or agent with respect to such securities; or (y) the provision to any Voting Party of any information
other than such information as a prudent issuer would generally furnish in an offering made solely to “accredited investors”
as defined in Regulation D promulgated under the Securities Act of 1933, as amended, the Company may cause to be paid to any such
Voting Party in lieu thereof, against surrender of the Shares which would have otherwise been sold by such Voting Party, an amount
in cash equal to the fair value (as determined in good faith by the Company) of the securities which such Voting Party would otherwise
receive as of the date of the issuance of such securities in exchange for the Shares; and

 

(g)          in
the event that the Selling Investors, in connection with such Change of Control Transaction, appoint a stockholder representative
(the “Stockholder Representative”) with respect to matters affecting the Voting Parties under the applicable
definitive transaction agreements following consummation of such Change of Control Transaction, (x) to consent to (i) the appointment
of such Stockholder Representative, (ii) the establishment of any applicable escrow, expense or similar fund in connection with
any indemnification or similar obligations, and (iii) the payment of such Stockholder’s pro rata portion (from the applicable
escrow or expense fund or otherwise) of any and all reasonable fees and expenses to such Stockholder Representative in connection
with such Stockholder Representative’s services and duties in connection with such Change of Control Transaction and its
related service as the representative of the stockholders, and (y) not to assert any claim or commence any suit against the Stockholder
Representative or any other Stockholder with respect to any action or inaction taken or failed to be taken by the Stockholder Representative
in connection with its service as the Stockholder Representative, absent fraud, bad faith or willful misconduct.

 

3.2         Conditions
to Drag-Along Right.  Notwithstanding the foregoing, a Voting Party shall only be required to comply with Section 3.1
above in connection with any proposed Change of Control Transaction (the “Proposed Sale”), subject to
the following conditions:

 

(a)          no
Voting Party shall be required to make any representation, covenant or warranty in connection with the Change of Control Transaction,
other than as to such Voting Party’s ownership and authority to sell, free of liens, claims and encumbrances, the shares
of common stock proposed to be sold by such Voting Party;

 

    	 	- 5 -	 

     

    

 

(b)          the
Voting Party shall not be liable for the inaccuracy of any representation or warranty made by any other individual, firm, corporation,
partnership, association, limited liability company, trust or any other entity (a “Person”) in connection
with the Proposed Sale, other than the Company (except to the extent that funds may be paid out of an escrow established to cover
breach of representations, warranties and covenants of the Company as well as breach by any stockholder of any of identical representations,
warranties and covenants provided by all stockholders);

 

(c)          the
liability for indemnification, if any, of such Voting Party in the Proposed Sale and for the inaccuracy of any representations
and warranties made by the Company or its stockholders in connection with such Proposed Sale, is several and not joint with any
other Person (except to the extent that funds may be paid out of an escrow established to cover breach of representations, warranties
and covenants of the Company as well as breach by any stockholder of any of identical representations, warranties and covenants
provided by all stockholders), and subject to the provisions of the Restated Certificate related to the allocation of the escrow,
is pro rata in proportion to, and does not exceed, the amount of consideration paid to such Voting Party in connection with such
Proposed Sale;

 

(d)          the
consideration payable with respect to each share in each class or series as a result of such Change of Control Transaction is the
same (except for cash payments in lieu of fractional shares) as for each other share in such class or series;

 

(e)          each
class and series of capital stock of the Company will be entitled to receive the same form of consideration (and be subject to
the same indemnity and escrow provisions) as a result of such Change of Control Transaction;

 

(f)           the
payment with respect to each share of common stock is an amount at least equal to the amount payable in accordance with the Company’s
certificate of incorporation, if such Change of Control Transaction were deemed a liquidation, dissolution or winding up pursuant
thereto; and

 

(g)          notwithstanding
the foregoing, if the consideration to be paid in exchange for the Shares held by a Holder or Investor, as applicable, pursuant
to this Section 3.2 includes any securities and due receipt thereof by any Holder or Investor would require under applicable
law (x) the registration or qualification of such securities or of any person as a broker or dealer or agent with respect
to such securities; or (y) the provision to any Holder or Investor of any information other than such information as a prudent
issuer would generally furnish in an offering made solely to “accredited investors” as defined in Regulation D promulgated
under the Securities Act, the Company may cause to be paid to any such Holder or Investor in lieu thereof, against surrender of
the Shares held by a Holder or Investor, as applicable, which would have otherwise been sold by such Holder or Investor, an amount
in cash equal to the fair value (as determined in good faith by the Company) of the securities which such Holder or Investor would
otherwise receive as of the date of the issuance of such securities in exchange for the Shares held by a Holder or Investor, as
applicable.

 

    	 	- 6 -	 

     

    

 

Section 4

 

TERMINATION

 

4.1         Termination.
This Agreement shall terminate upon the earliest of (i) the conversion of all outstanding shares of the Company’s preferred
stock into common stock; (ii) a Change of Control Transaction, provided that the provisions of Section 3 hereof
will continue after the closing of any Change of Control Transaction to the extent necessary to enforce the provisions of Section
3 with respect to such Change of Control Transaction; (iii) the consummation of the Company’s first underwritten public offering
of its common stock (other than a registration statement relating either to the sale of securities to employees of the Company
pursuant to its stock option, stock purchase or similar plan or an SEC Rule 145 transaction); or (iv) the agreement of a majority-in-interest
of the Holders and a majority-in-interest of the Investors, acting separately. “Change of Control Transaction”
means either (a) the acquisition of the Company by another entity by means of any transaction or series of related transactions
to which the Company is party (including, without limitation, any stock acquisition, reorganization, merger or consolidation but
excluding any sale of stock for capital raising purposes) that results in the voting securities of the Company outstanding immediately
prior thereto failing to represent immediately after such transaction or series of transactions (either by remaining outstanding
or by being converted into voting securities of the surviving entity or the entity that controls such surviving entity) a majority
of the total voting power represented by the outstanding voting securities of the Company, such surviving entity or the entity
that controls such surviving entity (a “Stock Sale”); or (b) a sale, lease or other conveyance of
all or substantially all of the assets of the Company.

 

Section 5

 

Additional Shares

 

5.1         Additional
Shares. In the event that subsequent to the date of this Agreement any shares or other securities (other than pursuant to a
Change of Control Transaction) are issued on, or in exchange for, any of the Shares by reason of any stock dividend, stock split,
consolidation of shares, reclassification or consolidation involving the Company, such shares or securities shall be deemed to
be Shares for purposes of this Agreement.

 

Section 6

 

Restrictive Legend

 

6.1         Restrictive
Legend. Each certificate representing any of the Shares subject to this Agreement shall be marked by the Company with a legend
reading substantially as follows:

 

THE SHARES EVIDENCED
HEREBY ARE SUBJECT TO A VOTING AGREEMENT (A COPY OF WHICH MAY BE OBTAINED FROM THE ISSUER) AND BY ACCEPTING ANY INTEREST IN SUCH
SHARES THE PERSON HOLDING SUCH INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL THE PROVISIONS OF SAID VOTING
AGREEMENT.

 

Section 7

 

miscellaneous

 

7.1         Certain
Definitions.  Shares “held” by a Voting Party shall mean any Shares directly or indirectly
owned (of record or beneficially) by such Voting Party or as to which such Voting Party has voting power. “Vote”
shall include any exercise of voting rights whether at an annual or special meeting or by written consent or in any other manner
permitted by applicable law. A “majority-in-interest” of either the Holders or the Investors shall mean
the holders of a majority of the common stock (determined on an as-converted basis) then held by such group.

 

    	 	- 7 -	 

     

    

 

7.2         Notices.  All
notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified
mail, postage prepaid, sent by facsimile or electronic mail (if to a Voting Party) or otherwise delivered by hand, messenger or
courier service addressed:

 

(a)          if
to a Voting Party, to the Voting Party’s address, facsimile number or electronic mail address, as shown in the exhibits to
this Agreement or in the Company’s records, as may be updated in accordance with the provisions hereof, or, until any such
Voting Party so furnishes an address, facsimile number or electronic mail address to the Company, then to the address, facsimile
number or electronic mail address of the last holder of the relevant Shares for which the Company has contact information in its
records; or

 

(b)          if
to the Company, to the attention of the Chief Executive Officer or Chief Financial Officer of the Company at 315 Montgomery Street,
Suite 100, San Francisco, CA 94104, or at such other address as the Company shall have furnished to the Voting Parties, with a
copy to Hill Ward Henderson, 101 East Kennedy Boulevard, Suite 3700, Tampa, Florida 33602, Attention: R. Reid Haney.

 

Each such notice or other
communication shall for all purposes of this Agreement be treated as effective or having been given (i) if delivered by hand,
messenger or courier service, when delivered, (or if sent via a nationally-recognized overnight courier service, freight prepaid,
specifying next-business-day delivery, one business day after deposit with the courier), or (ii) if sent via mail, at the earlier
of its receipt or five days after the same has been deposited in a regularly maintained receptacle for the deposit of the United
States mail, addressed and mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation of facsimile transfer or, (iv)
if sent via electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent during
normal business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s
next business day.

 

Subject to the limitations
set forth in Delaware General Corporation Law §232(e), each Voting Party consents to the delivery of any notice to stockholders
given by the Company under the Delaware General Corporation Law or the Company’s certificate of incorporation or bylaws by
(i) facsimile telecommunication to the facsimile number set forth in the exhibits to this Agreement (or to any other facsimile
number for the Voting Party in the Company’s records), (ii) electronic mail to the electronic mail address set forth in the
exhibits to this Agreement (or to any other electronic mail address for the Voting Party in the Company’s records), (iii)
posting on an electronic network together with separate notice to the Voting Party of such specific posting or (iv) any other form
of electronic transmission (as defined in the Delaware General Corporation Law) directed to the Voting Party. This consent may
be revoked by a Voting Party by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware
General Corporation Law §232.

 

7.3         Successors
and Assigns. The provisions of this Agreement shall inure to the benefit of, and be binding upon, the successors, assigns,
heirs, executors and administrators of the parties. The Company shall not permit the transfer of any Shares on its books or issue
a new certificate representing any Shares unless and until the person to whom such security is to be transferred shall have executed
a written agreement pursuant to which such person becomes a party to this Agreement and agrees to be bound by all the provisions
hereof as if such person was a Voting Party hereunder.

 

7.4         Governing
Law. This Agreement shall be governed in all respects by the internal laws of the State of Delaware, without regard to principles
of conflicts of law.

 

7.5         Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs and exhibits shall, unless
otherwise provided, refer to sections and paragraphs hereof and exhibits attached hereto.

 

    	 	- 8 -	 

     

    

 

7.6         Further
Assurances. Each party agrees to execute and deliver, by the proper exercise of its corporate, limited liability company, partnership
or other powers, all such other and additional instruments and documents and do all such other acts and things as may be necessary
to more fully effectuate this Agreement.

 

7.7         Entire
Agreement. This Agreement and the exhibits hereto constitute the full and entire understanding and agreement between the parties
with regard to the subjects hereof. No party shall be liable or bound to any other party in any manner with regard to the subjects
hereof or thereof by any warranties, representations or covenants except as specifically set forth herein.

 

7.8         No
Grant of Proxy. This Agreement does not grant any proxy and should not be interpreted as doing so. Nevertheless, should the
provisions of this Agreement be construed to constitute the granting of proxies, such proxies shall be deemed coupled with an interest
and are irrevocable for the term of this Agreement.

 

7.9         Not
a Voting Trust. This Agreement is not a voting trust governed by Section 218 of the Delaware
General Corporation Law and should not be interpreted as such.

 

7.10       Specific
Performance. It is agreed and understood that monetary damages would not adequately compensate an injured party for the breach
of this Agreement by any party, that this Agreement shall be specifically enforceable, and that any breach or threatened breach
of this Agreement shall be the proper subject of a temporary or permanent injunction or restraining order. Further, each party
waives any claim or defense that there is an adequate remedy at law for such breach or threatened breach.

 

7.11       Amendment.
Except as expressly provided herein, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated
other than by a written instrument referencing this Agreement and signed by (i) the Company, (ii) Holders holding a majority
of the common stock and (iii) Investors holding a majority of the common stock (determined on an as-converted basis) held
by all Investors; provided, however, that if any amendment, waiver, discharge or termination operates in a manner that treats
any Holder or Investor different from other Holders or Investors, as the case may be, the consent of such Holder or Investor shall
also be required for such amendment, waiver, discharge or termination and provided further, that any amendment waiver, discharge
or termination, shall require the written consent of (i) in the case of Section 2.2(a), Private Medical Equity, LLC Holdings,
Senju Pharmaceutical Co. Ltd. and Fred Eshelman for so long as each holds at least fifteen percent (15%) of the Shares initially
purchased by them (as adjusted for stock splits, dividends, combination, reorganizations and the like) and (ii) in the case of
Section 2.2(b), Point Guard Partners for so long as it holds at least fifteen percent (15%) of the Shares initially purchased
by it (as adjusted for stock splits, dividends, combination, reorganizations and the like). Any such amendment, waiver, discharge
or termination effected in accordance with this paragraph shall be binding upon each Voting Party that has entered into this voting
agreement. Each Voting Party acknowledges that by the operation of this paragraph, the holders of a majority of the common stock
held by all Holders and the holders of a majority of the common stock (determined on an as-converted basis) held by all Investors
will have the right and power to diminish or eliminate all rights of such Voting Party under this Agreement.

 

7.12       No
Waiver. The failure or delay by a party to enforce any provision of this Agreement will not in any way be construed as a waiver
of any such provision or prevent that party from thereafter enforcing any other provision of this Agreement. The rights granted
both parties hereunder are cumulative and will not constitute a waiver of either party’s right to assert any other legal
remedy available to it.

 

    	 	- 9 -	 

     

    

 

7.13       Attorney’s
Fees. In the event that any suit or action is instituted to enforce any provision in this Agreement, the prevailing party in
such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such prevailing
party under or with respect to this Agreement, including without limitation, such reasonable fees and expenses of attorneys and
accountants, which shall include, without limitation, all fees, costs and expenses of appeals.

 

7.14       Severability.
If any provision of this Agreement becomes or is declared by a court of competent jurisdiction to
be illegal, unenforceable or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall
be severed from this Agreement, and such court will replace such illegal, void or unenforceable provision of this Agreement with
a valid and enforceable provision that will achieve, to the extent possible, the same economic, business and other purposes of
the illegal, void or unenforceable provision. The balance of this Agreement shall be enforceable in accordance with its terms.

 

7.15       Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which together
will constitute one and the same agreement. Facsimile copies of signed signature pages will be deemed binding originals.

 

7.16       Dispute
Resolution. EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT TO TRIAL BY
JURY IN ANY LEGAL PROCEEDING (WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS AGREEMENT.

 

(signature page follows)

 

    	 	- 10 -	 

     

    

 

The parties are signing
this Amended and Restated Voting Agreement as of the date stated in the introductory clause.

 

	 	EYENOVIA, INC.,
	 	a Delaware corporation
	 	 	 	 
	 	By:	/s/ Tsontcho Ianchulev
	 	 	Name:  	Tsontcho Ianchulev
	 	 	Title:	Chief Executive Officer

 

(Signature Page to Amended & Restated
Voting Agreement)

 

     

     

    

 

The party below hereby
agrees, effective ______________, 2017, to become a party to this Amended and Restated Voting Agreement and for all purposes of
this Amended and Restated Voting Agreement the party below shall be included within the term Investor.

 

	 	INVESTOR:
	 	 
	 	 
	 	(Print investor name)
	 	 
	 	 
	 	(Signature)
	 	 
	 	 
	 	(Print name of signatory, if signing for an entity)
	 	 
	 	 
	 	(Print title of signatory, if signing for an entity)

 

(Signature Page to Amended & Restated
Voting Agreement)

 

     

     

    

 

Schedule 1

Series A Investors

 

	Name, Address and E-Mail
	 
	 

 

     

     

    

 

Schedule 2

Series A-2 Investors

 

	Name, Address and E-Mail
	 
	 

 

     

     

    

 

Schedule 3

Series B Investors

 

	Name, Address and E-Mail
	 
	 

 

     

     

    

 

Schedule 4

Holders

 

	Name, Address and E-Mail

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}]]